Article
Identification of a Costimulatory Molecule-Related Signature for Predicting Prognostic Risk in Prostate Cancer
16 Aug 2021
Abstract excerpt
Costimulatory molecules have been proven to enhance antitumor immune responses, but their roles in prostate cancer (PCa) remain unexplored. In this study, we aimed to explore the gene expression profiles of costimulatory molecule genes in PCa and construct a prognostic signature to improve treatment decision making and clinical outcomes. Five prognosis-related costimulatory molecule genes (RELT, TNFRSF25, EDA2R,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
